TEL AVIV, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...

Dear Shareholders, 2025 has been a transformational year for Nasus Pharma. We’ve made considerable progress building a strong, focused company with significant clinical impact, by developing drug ...

TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...

TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative ...

TEL AVIV, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma", "Nasus" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative ...

Every few years, the pharmaceutical industry quietly reminds the market of an uncomfortable truth: the biggest value creation doesn’t always come from discovering a brand-new drug. Sometimes, it comes ...

Nasus is a late bloomer in League of Legends. The champion can be one of the most powerful tanks in the game if players use him correctly. Gamers need to take a conservative approach in the first five ...

Number-fact #1: there are 116 champions in League of Legends today, and plenty more to come. Number-fact #2: there are 365 days in a year, and the character models in this four year old game look a ...

Everyone hates Nasus at one point or other. Even Nasus players hate playing against Nasus. Why? Because he is pure, high-octane bullshit that can 1v5 your entire team if you let him just do his job.

On September 28, 2022, League of Legends released a major number of changes for Nasus in its PBE (Public Beta Environment). It has been a while since Nasus received buffs within the game, but it looks ...

TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...